Matrix Capital Management Company, LP
SEC CIK 1410830 · EDGAR
BoughtSold
Most active insiders at AURA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Matrix Capital Management Company, LP | 10% | — | $39.04M |
| 2 | de los Pinos Elisabet | See Remarks, Dir | — | $380.8K |
| 3 | Hopkins Janet Jill | Chief Medical Off | — | $196.0K |
| 4 | Plavsic Mark | CTO | — | $157.5K |
| 5 | Kilroy Conor | See Remarks | — | $143.4K |
| 6 | Gibney Anthony S | See Remarks | — | $82.3K |
| 7 | Elazzouzi Amy | SVP, Fin, PAO | — | $56.6K |
| 8 | Kratz Erica | Chief Reg, Quality Off | — | — |
| 9 | Abu-Absi Susan | COO | — | — |
| 10 | Bitetti Teresa Marie | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-11 16:16 | 2026-05-07 | AURA | Aura Biosciences, Inc. | Matrix Capital Management Company, LP | 10% | S - Sale | $5.64 | -6.92M | 0 | -100% | -$39.04M |
| I | 2023-11-09 | 2023-11-09 | AURA | Aura Biosciences, Inc. | Matrix Capital Management Company, LP | 10% | P - Purchase | $9.00 | +1.56M | 6.92M | +29% | +$14.04M |
| I | 2023-06-20 | 2023-06-20 | ZNTL | Zentalis Pharmaceuticals, Inc. | Matrix Capital Management Company, LP | 10% | P - Purchase | $22.66 | +4.76M | 13.96M | +52% | +$107.86M |
| I | 2022-12-07 | 2022-12-05 | AURA | Aura Biosciences, Inc. | Matrix Capital Management Company, LP | 10% | P - Purchase | $12.00 | +1.25M | 5.36M | +30% | +$15.00M |
Purchase Sale Sale after option exercise All abbreviations